Development and evaluation of a nomogram prediction model for invasion and metastasis in primary liver cancer based on serum CD147 and IL-6.
[OBJECTIVE] This study aims to develop a prediction model for invasive metastasis of primary liver cancer based on serum extracellular matrix metalloproteinase-inducing factor (CD147) and interleukin-
- 95% CI 0.741-0.939
APA
Zhang W, Wu D, et al. (2025). Development and evaluation of a nomogram prediction model for invasion and metastasis in primary liver cancer based on serum CD147 and IL-6.. Frontiers in oncology, 15, 1524765. https://doi.org/10.3389/fonc.2025.1524765
MLA
Zhang W, et al.. "Development and evaluation of a nomogram prediction model for invasion and metastasis in primary liver cancer based on serum CD147 and IL-6.." Frontiers in oncology, vol. 15, 2025, pp. 1524765.
PMID
40919145
Abstract
[OBJECTIVE] This study aims to develop a prediction model for invasive metastasis of primary liver cancer based on serum extracellular matrix metalloproteinase-inducing factor (CD147) and interleukin-6 (IL-6).
[METHODS] Between July 2022 and August 2024, 170 surgically treated primary hepatocellular carcinoma patients at our hospital were recruited. They were divided into a training group ( = 120) and a validation group ( = 50) at a 7:3 ratio. Univariate and multivariate logistic regression analyses were applied in the training group to identify factors related to invasive metastasis. A risk factor-based bar chart prediction model was then constructed and internally tested. Its goodness of fit was evaluated, and the model's diagnostic efficacy was assessed using the ROC curve. Finally, decision curve analysis (DCA) was performed to evaluate the model's clinical value.
[RESULTS] In the training group, compared with the noninvasive metastasis group, patients in the invasive metastasis group had a significantly lower percentage of intact envelope and tumor size ≥5 cm, and significantly higher serum alpha-fetoprotein (AFP), alkaline phosphatase (ALP), C-reactive protein/albumin ratio (CAR), oncoglobulin (CEA), CD147, and IL-6 levels (all < 0.05). After logistic multifactorial analysis, intact envelope, tumor > 5 cm, AFP, CAR, CD147, and IL-6 were identified as independent influencing factors for invasive metastasis of primary hepatocellular carcinoma (all < 0.05). A column chart model was constructed. The C-index of the training and validation groups was 0.884 (95% confidence interval [CI]: 0.738-0.932) and 0.841 (95% CI: 0.741-0.939), respectively. The calibration curves showed good agreement between the predicted probability and the actual probability in both the training and validation groups, without significant deviation. The area under the curve (AUC) of the ROC analysis was 0.852 (95% CI: 0.824-0.979) and 0.839 (95% CI: 0.791-0.912), respectively. DCA indicated that the model had clinical application value within a certain range of threshold probabilities.
[CONCLUSION] The prediction model based on serum CD147, IL-6, and other risk factors for the invasion and metastasis of primary hepatocellular carcinoma demonstrates high diagnostic value.
[METHODS] Between July 2022 and August 2024, 170 surgically treated primary hepatocellular carcinoma patients at our hospital were recruited. They were divided into a training group ( = 120) and a validation group ( = 50) at a 7:3 ratio. Univariate and multivariate logistic regression analyses were applied in the training group to identify factors related to invasive metastasis. A risk factor-based bar chart prediction model was then constructed and internally tested. Its goodness of fit was evaluated, and the model's diagnostic efficacy was assessed using the ROC curve. Finally, decision curve analysis (DCA) was performed to evaluate the model's clinical value.
[RESULTS] In the training group, compared with the noninvasive metastasis group, patients in the invasive metastasis group had a significantly lower percentage of intact envelope and tumor size ≥5 cm, and significantly higher serum alpha-fetoprotein (AFP), alkaline phosphatase (ALP), C-reactive protein/albumin ratio (CAR), oncoglobulin (CEA), CD147, and IL-6 levels (all < 0.05). After logistic multifactorial analysis, intact envelope, tumor > 5 cm, AFP, CAR, CD147, and IL-6 were identified as independent influencing factors for invasive metastasis of primary hepatocellular carcinoma (all < 0.05). A column chart model was constructed. The C-index of the training and validation groups was 0.884 (95% confidence interval [CI]: 0.738-0.932) and 0.841 (95% CI: 0.741-0.939), respectively. The calibration curves showed good agreement between the predicted probability and the actual probability in both the training and validation groups, without significant deviation. The area under the curve (AUC) of the ROC analysis was 0.852 (95% CI: 0.824-0.979) and 0.839 (95% CI: 0.791-0.912), respectively. DCA indicated that the model had clinical application value within a certain range of threshold probabilities.
[CONCLUSION] The prediction model based on serum CD147, IL-6, and other risk factors for the invasion and metastasis of primary hepatocellular carcinoma demonstrates high diagnostic value.
같은 제1저자의 인용 많은 논문 (5)
- USP32 Promotes Cancer Cell Invasion, Macrophage M2 Polarization, and CD8+ T Cell Apoptosis in Gastric Cancer Through Upregulation of DAPK1.
- Challenges to case-only analysis for interaction detection using polygenic risk scores: model assumptions and biases in large biobanks.
- United multi-omics and machine learning refine regulatory T cell-defined hepatocellular carcinoma subtypes.
- A SLC7A5-Specific Near-Infrared Fluorescent Probe for Cancer-Targeted Imaging Applications.
- Dynamic liver dysfunction predicts poor survival in patients with EGFR-mutant non-small cell lung cancer and liver metastases treated with EGFR tyrosine kinase inhibitors.